{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:08:54Z","timestamp":1793945334630,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007343","name":"University of Brescia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijid.2025.107849","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:04:07Z","timestamp":1740222247000},"page":"107849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5109-9248","authenticated-orcid":false,"given":"Alberto","family":"Matteelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lovatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107849_bib0001","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB \u2013 latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0002","series-title":"WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"10.1016\/j.ijid.2025.107849_bib0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","article-title":"Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling","volume":"19","author":"Knight","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.107849_bib0005","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1038\/s41598-024-58080-0","article-title":"Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta town, Northwest Ethiopia: a five-year retrospective study","volume":"14","author":"Limenh","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2025.107849_bib0006","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.ijid.2022.08.015","article-title":"Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in central and West Africa: a systematic review and meta-analysis","volume":"124","author":"Toft","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0007","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1473-3099(23)00372-9","article-title":"Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews","volume":"23","author":"Litvinjenko","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0008","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's New End TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.107849_bib0009","article-title":"Tuberculosis and COVID-19 co-infection: description of the global cohort","volume":"59","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2025.107849_bib0010","article-title":"Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort","volume":"62","author":"Casco","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2025.107849_bib0011","series-title":"Global Tuberculosis Report","year":"2024"},{"key":"10.1016\/j.ijid.2025.107849_bib0012","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","article-title":"25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward","volume":"22","author":"Dean","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0013","series-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","year":"2022"},{"key":"10.1016\/j.ijid.2025.107849_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.107849_bib0015","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"10.1016\/j.ijid.2025.107849_bib0016","series-title":"The end TB strategy","year":"2015"},{"key":"10.1016\/j.ijid.2025.107849_bib0017","series-title":"Guidelines on the management of latent tuberculosis infection","year":"2014"},{"key":"10.1016\/j.ijid.2025.107849_bib0018","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa2314325","article-title":"Levofloxacin for the prevention of multidrug-resistant tuberculosis in Vietnam","volume":"391","author":"Fox","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.107849_bib0019","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2314318","article-title":"Levofloxacin preventive treatment in children exposed to MDR tuberculosis","volume":"391","author":"Hesseling","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.107849_bib0020","unstructured":"ClinicalTrails.gov. Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients (Phoenix MDR-TB), https:\/\/clinicaltrials.gov\/study\/NCT03568383; 2019 [accessed 20 January 2025]."},{"key":"10.1016\/j.ijid.2025.107849_bib0021","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2025.107849_bib0022","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0023","series-title":"WHO consolidated guidelines on tuberculosis. Module 1: prevention tuberculosis preventive treatment","year":"2024"},{"key":"10.1016\/j.ijid.2025.107849_bib0024","series-title":"WHO operational handbook on tuberculosis. Module 5: management of tuberculosis in children and adolescents","year":"2022"},{"key":"10.1016\/j.ijid.2025.107849_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cmi.2023.09.015","article-title":"Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"30","author":"Zhou","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2025.107849_bib0026","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400190","article-title":"A meta-analysis of levofloxacin for contacts of multidrug-resistant tuberculosis","volume":"4","author":"Duong","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ijid.2025.107849_bib0027","unstructured":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2024 - 2022 data. Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control; 2024. Licence: CC BY 3.0 IGO: Available at: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/TB_Surveillance_Report_2024.pdf, Accessed 24 March 2025."},{"key":"10.1016\/j.ijid.2025.107849_bib0028","unstructured":"ClinicalTrails.gov. Bedaquiline roll-out evidence in contacts and people living with HIV to prevent TB (BREACH-TB), https:\/\/clinicaltrials.gov\/study\/NCT06568484?term=Bedaquiline%20Roll-out%20Evidence%20in%20Contacts%20and%20People%20Living%20With%20HIV%20to%20Prevent%20TB&rank=1; 2024 [accessed 20 January 2025]."},{"key":"10.1016\/j.ijid.2025.107849_bib0029","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40265-024-02131-3","article-title":"Tuberculosis preventive treatment in high TB-burden settings: a state-of-the-art review","volume":"85","author":"Chihota","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2025.107849_bib0030","doi-asserted-by":"crossref","first-page":"858","DOI":"10.5588\/ijtld.17.0809","article-title":"Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study","volume":"22","author":"Hirsch-Moverman","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107849_bib0031","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/INF.0000000000002268","article-title":"Acceptability of a novel levofloxacin dispersible tablet formulation in young children exposed to multidrug-resistant tuberculosis","volume":"38","author":"Purchase","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2025.107849_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268560","article-title":"Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children","volume":"17","author":"Wademan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107849_bib0033","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5588\/ijtldopen.24.0350","article-title":"TB prevention activities in the WHO European region","volume":"1","author":"Matteelli","year":"2024","journal-title":"IJTLD Open"},{"key":"10.1016\/j.ijid.2025.107849_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","article-title":"Preventive therapy for latent tuberculosis infection-the promise and the challenges","volume":"56","author":"Fox","year":"2017","journal-title":"Int J Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:42:16Z","timestamp":1770205336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S1201971225000724"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107849","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107849"}}